Colinz Laboratories Ltd
₹43.47
(4.75%)
Wed, 18 Mar 2026, 03:21 am
Colinz Laboratories Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 304 | 25.89 | 55.56 | 26.75 | 38.71 | 28 | 70.48 | 82.86 | 60.97 | 29.20 | 24.45 | 31.29 | 16.74 | 31.73 | 19.28 | 19.44 | 36.75 |
| Price to book ratio | 0.38 | 0.29 | 0.52 | 0.50 | 0.51 | 0.32 | 1.16 | 1.35 | 1.40 | 1.04 | 0.43 | 0.60 | 0.48 | 1.40 | 1.08 | 1.06 | 1.93 |
| Price to sales ratio | 0.54 | 0.42 | 0.71 | 0.44 | 0.42 | 0.26 | 0.86 | 0.98 | 1.13 | 0.85 | 0.39 | 0.54 | 0.56 | 1.54 | 1.23 | 1.35 | 2.80 |
| Price to cash flow ratio | 14.13 | 5.40 | 5.12 | 9.65 | 19.93 | 3 | 71.50 | 13.79 | 121.78 | 9.68 | 0 | 4.33 | 2.13 | 10.06 | 12.02 | 9.70 | 0 |
| Enterprise value | 56.47M | 47.1M | 57.39M | 44.01M | 43.25M | 25.99M | 73.2M | 79.33M | 77.65M | 52.24M | 16.58M | 18.65M | -2.15M | 60.43M | 33.61M | 30.29M | 133.39M |
| Enterprise value to EBITDA ratio | 10.63 | 9.81 | 12.21 | 8.59 | 8.30 | 7.52 | 16.11 | 17.59 | 18.97 | 14.57 | 4.73 | 6.16 | -0.65 | 10.31 | 5.31 | 5.58 | 26.83 |
| Debt to equity ratio | 0.54 | 0.53 | 0.47 | 0.41 | 0.38 | 0.31 | 0.40 | 0.27 | 0.12 | 0.07 | 0.10 | 0.06 | 0.14 | 0.06 | 0.03 | 0.06 | 0.07 |
| Return on equity % | 0 | 1.46 | 1.22 | 1.86 | 1.36 | 1.12 | 1.64 | 1.61 | 2.34 | 3.69 | 1.84 | 1.91 | 2.94 | 4.53 | 5.78 | 5.70 | 5.39 |
Colinz Laboratories Ltd Enterprise Value
The Colinz Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Colinz Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Colinz Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Colinz Laboratories Ltd (NSE: , BSE: 531210) is currently trading at ₹43.47, with a market capitalization of ₹104.54M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Colinz Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Colinz Laboratories Ltd Enterprise Value Current Value
The current Colinz Laboratories Ltd Enterprise Value stands at 133.39M.
The latest Colinz Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Colinz Laboratories Ltd Enterprise Value Historical Trend
The Colinz Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 133.39M
- 2023: 30.29M
- 2022: 33.61M
- 2021: 60.43M
- 2020: -2.15M
The recent rise in Colinz Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Colinz Laboratories Ltd Enterprise Value Indicates for Investors
The Colinz Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Colinz Laboratories Ltd.
Colinz Laboratories Ltd Enterprise Value Analysis Summary
The Colinz Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Colinz Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Colinz Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800